Company · founded 1961
Advanced Bioscience Laboratories (United States)
Rockville, United States · ablinc.com
- Citations, last 5 years
- 130
- Works, last 5 years
- 11
- h-index
- 96
- Scientists listed
- 4
- Grants since 2016
- 173
Grants received
2025–2028 · contract · N01
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2025–2026 · contract · N01
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Trained Human Sensory Panels
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2025 · contract · N01
NIAID Preclinical Development Support - Production of a HIV gp145 Clade C Trimer Protein
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2024–2030 · contract · N01
Expertise in Professional Pharmaceutical Project Management
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2024–2028 · contract · N01
Feasibility for Development of a Liposome/LNP Displaying an HIV Env Trimer Protein and Containing/Incorporating an mRNA
Timothy R Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2024–2025 · contract · N01
Participation in a Workshop on Development of Animal Models Supporting Pediatric Formulation Development
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2024–2027 · contract · N01
MANUFACTURE AND PRECLINICAL TESTING OF SITE BLOCKING OLIGONUCLEOTIDES (SBO)
Cary Retterer · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2024–2026 · contract · N01
LEAD CANDIDATE IDENTIFICATION PK AND TOXICOLOGY STUDIES FOR ANTIBODY PROJECT IN BLUEPRINT NEUROTHERAPEUTICS (BPN) BIOLOGICS PROGRAM
Kumar Reddy · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2024–2025 · contract · N01
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2023–2028 · contract · N01
TASK V31: PROCESS DEVELOPMENT FOR PANFUNGAL VACCINES
Tim Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2023–2025 · contract · N01
Task V31: Process Development for Panfungal Vaccine
Tim Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2023–2030 · contract · N01
Task Area B: NIAID Preclinical Services for AMR Diagnostics Development
Christina Mayer · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2023–2024 · contract · N01
Task V33: Manufacturing of Master Cell Bank Production and Formulation Development for Antibacterial resistance
Christine Meyer · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2023–2030 · contract · N01
Expertise in Development of Pediatric Drug Formulations
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2023–2030 · contract · N01
Expertise in Development of Pediatric Drug Formulations
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2023–2024 · contract · N01
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2023–2030 · contract · N01
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2023 · contract · N01
Task X5: Master Cell Bank for Chlamydia Trachoma Vaccine
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N01
Support for Enhancing Study Drug Adherence in HIV Prevention Trials
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N01
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Scientific and Quality/Regulatory Support Services
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N01
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC)
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N01
Advancing the Development of Pediatric Drug Formulations: Planning and Implementation of a DAIDS-Industry Pediatric Formulation Partnership and Pediatric Drug Formulation Think Tank
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2022–2024 · contract · N01
NIAID Preclinical Development Support: Essential Core Activities
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2021–2024 · contract · N01
Stability Testing of HIV Antibodies and Reagents Used in Downstream Process Purification
Fouts Timothy · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2021–2023 · contract · N01
Task V27: Stability Testing of CpG
Andreas Neubert · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2021–2022 · contract · N01
Statistical and Pharmacometric Modeling Support for HIV Non-Vaccine Biomedical Prevention Product Development
Maria Grazia Ferrari · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2021–2022 · contract · N01
Support for Enhancing Study Drug Adherence in HIV Prevention Trials
Maria Grazia Ferrari · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2021–2022 · contract · N01
Ethnographic Expertise for Enhancing Study Drug Adherence in HIV Prevention Trials
Maria Grazia Ferrari · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2020–2021 · contract · N01
STATISTICAL AND PHARMACOMETRIC MODELING SUPPORT FOR HIV NON-VACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT
Maria Grazia Ferrari · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2020–2021 · contract · N01
Scientific and Quality/Regulatory Support Services: Data Integrity Consultation
Maria Ferrari · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2020–2021 · contract · N01
Quality Evaluation and ISO Biocompatibility Studies Supporting a Cabotegravir Implant for HIV Prevention
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2020–2021 · contract · N01
Advancing the Development of Pediatric Drug Formulations: Planning and Implementation of a DAIDS-Industry Pediatric Formulation Partnership and Pediatric Drug Formulation Think Tank
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2020–2021 · contract · N01
Expertise in Development of Pediatric Drug Formulations
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2020 · contract · N01
Procurement of cGMP QS21 and Production of cGMP ALF55 Drug Substance
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2019–2020 · contract · N01
Support for Enhancing Study Drug Adherence in HIV Prevention Trials
Glen Swartz · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2019–2024 · contract · N01
cGMP Manufacturing of Glycopeptide Immunogen Nanoparticle Vaccine
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2019–2021 · contract · N01
Manufacture of a Vaccine Targeting Frame-Shift Mutations Characteristic of Tumors with Microsatellite Instability
Beth Tebeau · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2019–2020 · contract · N01
Manufacture of a Vaccine Targeting Frame-Shift Mutations Characteristic of Tumors with Microsatellite Instability
Beth Tebeau · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2019–2023 · contract · N01
Characterization of the Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of a Candidate HIV Prevention Drug in Rhesus Macaques
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2019–2020 · contract · N01
Essential Core Activities: NIAID Preclinical Development Support
Thomas Vancott · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health